Pharmaceutical companies must keep improving Covid-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, a provider for the biopharma industry. The report This data, included in Informa Pharma’s ‘Q4 2021 Clinical Trials and the Covid 19 Landscape’ report, is […]